Swiss stocks - Factors to watch on Feb 18
ZURICH Feb 18 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Monday:
* Chairman Daniel Vasella said he will receive up to 72 million Swiss francs ($77.94 million) over the next six years after leaving the company this month, news that might play into the hands of supporters of a referendum to limit "fat cat" pay.
The news has unleashed a wave of indignation among activist shareholders and politicians.
* U.S. regulators approved Novartis AG's Zortress as the first new drug in more than a decade for preventing organ rejection in adult patients receiving a liver transplant, the company said on Friday.For related news click on
* Nobel Biocare shareholder Oskar Ronner published a statement saying he no longer wished to join the board of directors after the board rejected the election of two other candidates he had proposed.
Trending On Reuters
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video